Literature DB >> 15172451

MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epitopes detect reliably specific CD4(+) T cells in healthy volunteers.

Ming Ye1, Suha Kasey, Sumit Khurana, Nga T Nguyen, Scott Schubert, C Thomas Nugent, Kristine Kuus-Reichel, Johannes Hampl.   

Abstract

Tracking antigen specific T cells with major histocompatibility complex (MHC) tetramers has provided us with insights into the dynamics of the adaptive immune system and holds great promise to aid in patient management and drug and vaccine development. Progress has been made primarily using MHC class I tetramers to monitor CD8(+) T cells, whereas corresponding efforts to stain CD4(+) T cells with class II tetramers have not been as successful. Two major reasons have been proposed for this lack of progress: (1). The frequency of antigen-specific CD4(+) T cells is lower than the frequency of CD8(+) T cells and (2). some, but not all, antigen- specific CD4(+) T cells can bind tetramer because of low functional avidity. In this study, we asked if CD4(+) T cells specific for common human viruses (e.g., influenza and Epstein-Barr) can be detected in healthy individuals previously exposed to them. We were able to clearly detect specific CD4(+) T cells in all donors after in vitro expansion of peripheral blood mononuclear cells. Furthermore, we observe a clear separation of tetramer negative and tetramer positive CD4(+) T cells in most samples similar to patterns commonly seen with class I tetramers. The data indicate that MHC class II tetramers can be used reliably for the identification of CD4(+) T cells specific for ubiquitous infectious agents in normal donors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172451     DOI: 10.1016/j.humimm.2004.02.019

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

Review 1.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

Review 2.  MHC class II tetramers.

Authors:  Gerald T Nepom
Journal:  J Immunol       Date:  2012-03-15       Impact factor: 5.422

3.  Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.

Authors:  Hirohisa Nose; Ryuji Kubota; Nilufer P Seth; Peter K Goon; Yuetsu Tanaka; Shuji Izumo; Koichiro Usuku; Yoshiro Ohara; Kai W Wucherpfennig; Charles R M Bangham; Mitsuhiro Osame; Mineki Saito
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

4.  Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.

Authors:  Meredith L Leong; Johannes Hampl; Weiqun Liu; Shruti Mathur; Keith S Bahjat; William Luckett; Thomas W Dubensky; Dirk G Brockstedt
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

5.  CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant.

Authors:  Albert C Yeh; Antiopi Varelias; Anupama Reddy; Sierra M Barone; Stuart D Olver; Kate Chilson; Lynn E Onstad; Kathleen S Ensbey; Andrea S Henden; Luke Samson; Carla A Jaeger; Timothy Bi; Kimberly B Dahlman; Tae Kon Kim; Ping Zhang; Mariapia A Degli-Esposti; Evan W Newell; Madan H Jagasia; Jonathan M Irish; Stephanie J Lee; Geoffrey R Hill
Journal:  Blood       Date:  2021-12-30       Impact factor: 25.476

6.  Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.

Authors:  Julien Schmidt; Danijel Dojcinovic; Philippe Guillaume; Immanuel Luescher
Journal:  Front Immunol       Date:  2013-07-30       Impact factor: 7.561

7.  Peptide Epitope Hot Spots of CD4 T Cell Recognition Within Influenza Hemagglutinin During the Primary Response to Infection.

Authors:  Zackery A G Knowlden; Katherine A Richards; Savannah A Moritzky; Andrea J Sant
Journal:  Pathogens       Date:  2019-11-05

Review 8.  The role of cell-mediated immunity against influenza and its implications for vaccine evaluation.

Authors:  Yorick Janssens; Jasper Joye; Gwenn Waerlop; Frédéric Clement; Geert Leroux-Roels; Isabel Leroux-Roels
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

9.  HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients.

Authors:  Hans-Henning Schmidt; Yingzi Ge; Felix J Hartmann; Heinke Conrad; Felix Klug; Sina Nittel; Helga Bernhard; Christoph Domschke; Florian Schuetz; Christof Sohn; Philipp Beckhove
Journal:  Oncoimmunology       Date:  2013-05-15       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.